首页> 外国专利> SYSTEM FOR EVALUATING PROFITABILITY OF DEVELOPED MEDICINE

SYSTEM FOR EVALUATING PROFITABILITY OF DEVELOPED MEDICINE

机译:评价已开发药物的能力的系统

摘要

A system (10) for evaluating the profitability of a developed medicine has a data set creating subsystem (100) and a management index calculating subsyst em (200). The data set creating subsystem includes a sales total predicting uni t (110), an expense predicting unit (120), a net present value (NPV) calculati ng section (131), an internal rate-of-return (IRR) calculating unit (140), a repetitively calculating unit (150), for creating a data set in which the values calculated by the predicting units and calculating units are varied within a predetermined distribution width, and a data set recording unit (160). The management index calculating subsystem includes a volatility calculating unit (201), an option value calculating unit (202), and a projec t value calculating unit (203). Thus, the system evaluates the investment profitability of the research and development of a medicine by using a real option method.
机译:用于评估已开发药品的获利能力的系统(10)具有数据集创建子系统(100)和管理指数计算子系统(200)。数据集创建子系统包括销售总额预测单位(110),费用预测单元(120),净现值(NPV)计算部分(131),内部收益率(IRR)计算单元(140),重复计算单元(150)和数据集记录单元(160),该数据集用于创建由预测单元和计算单元计算出的值在预定分布宽度内变化的数据集。管理指标计算子系统包括波动率计算单元(201),期权价值计算单元(202)和项目价值计算单元(203)。因此,该系统通过使用实物期权方法评估药物研发的投资收益率。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号